Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors - Bertin Instruments

    Scientific publications

    Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors

    Beverly L. Falcon1, Sharon Barr2, Prafulla C. Gokhale2, Jeyling Chou1, Jennifer Fogarty1, Philippe Depeille1, Mark Miglarese2, David M. Epstein2, and Donald M. McDonald1
    Sources: 1Cardiovascular Research Institute, Comprehensive Cancer Center, and Department of Anatomy, University of California, San Francisco, California; and 2OSI Pharmaceuticals, Inc., Farmingdale, New York
    doi: 10.1158/0008-5472.CAN-10-3126 Cancer Res March 1, 2011 71; 1Forensic

    Sample name

    Human tissues (tumors)

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question